Mackenzie Financial Corp Purchases 14,949 Shares of Waters Co. (NYSE:WAT)

Mackenzie Financial Corp lifted its position in shares of Waters Co. (NYSE:WAT) by 7.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 209,538 shares of the medical instruments supplier’s stock after acquiring an additional 14,949 shares during the quarter. Mackenzie Financial Corp’s holdings in Waters were worth $60,791,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Foguth Wealth Management LLC. purchased a new position in shares of Waters in the first quarter worth about $2,773,000. Virtu Financial LLC bought a new position in Waters in the 4th quarter worth about $962,000. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its holdings in Waters by 2,134.3% during the 1st quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 5,921 shares of the medical instruments supplier’s stock valued at $2,038,000 after buying an additional 5,656 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Waters by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 6,837,662 shares of the medical instruments supplier’s stock valued at $2,251,163,000 after buying an additional 64,525 shares during the period. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Waters by 223.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 8,222 shares of the medical instruments supplier’s stock worth $2,707,000 after buying an additional 5,683 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Stock Up 0.5 %

Shares of Waters stock opened at $357.33 on Friday. The company’s 50 day moving average price is $333.53 and its 200-day moving average price is $324.35. Waters Co. has a 52-week low of $231.90 and a 52-week high of $367.21. The stock has a market capitalization of $21.21 billion, a price-to-earnings ratio of 35.07, a P/E/G ratio of 5.96 and a beta of 0.95. The company has a debt-to-equity ratio of 1.42, a quick ratio of 1.42 and a current ratio of 2.10.

Waters (NYSE:WAT) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share for the quarter, topping analysts’ consensus estimates of $2.55 by $0.08. Waters had a return on equity of 56.81% and a net margin of 20.71%. The firm had revenue of $709.00 million for the quarter, compared to analyst estimates of $700.09 million. During the same period last year, the company earned $2.80 EPS. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. Equities research analysts forecast that Waters Co. will post 11.6 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on WAT. Jefferies Financial Group began coverage on shares of Waters in a research note on Monday, June 3rd. They set a “hold” rating and a $320.00 price objective for the company. TD Cowen boosted their price objective on Waters from $325.00 to $363.00 and gave the stock a “hold” rating in a report on Thursday, August 1st. The Goldman Sachs Group raised shares of Waters to a “hold” rating in a research note on Wednesday, July 31st. Barclays boosted their price target on shares of Waters from $275.00 to $300.00 and gave the stock an “underweight” rating in a research note on Thursday, August 1st. Finally, Wells Fargo & Company started coverage on Waters in a research report on Tuesday, August 27th. They set an “overweight” rating and a $380.00 price target on the stock. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $318.50.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.